The Investigators propose a multi-center, observational, longitudinal, cohort study of the serology and wellness of HCWs over a year of the COVID-19 pandemic.
All consenting participants will undergo survey assessment and diagnostic testing with the
Abbott Architect SARS-CoV-2 IgG assay (IgG) every three months for a one year period.
Clinical outcomes and related data capture will be performed at this same interval.
Inclusion Criteria:
1. Age greater than or equal to 18 years; and
2. Be an active member of the CommonSpirit Health workforce or medical staff during the
COVID-19 pandemic and at the time of enrollment; and
3. Have access to the Internet; and
4. The ability to provide informed consent.
Exclusion Criteria:
1. Subjects that lack the ability for longitudinal follow-up; and/or
2. Subjects that do not meet the above inclusion criteria. -
Chandler Regional Medical Center
Chandler, Arizona, United States
Investigator: Jennine Zumbuhl, RN, MSHA
Contact: 480-728-3674
jennine.zumbuhl@dignityhealth.org
Andrea B. Garcia, MBA
602-406-9769
andrea.garcia2@dignityhealth.org
Jennine Zumbuhl, RN, MSHA
480-728-3674
jennine.zumbuhl@dignityhealth.org
Brian Tiffany, MD, PhD, Principal Investigator
Chief Medical Officer Dignity Health Arizona